Study of Escitalopram in the Treatment of Specific Phobia

Clinical trial NCT00121069 · COMPLETED

Trial details

NCT number: NCT00121069
Sponsor: Connor, Kathryn M., M.D.
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Phobic Disorders

Start date: 2002-09-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.